Phospho-Akt: a potential resistance marker to chemotherapy and therapy-target to restore sensitivity in pancreatic cancer

Autor: Daniela Massihnia, Antonio Russo, Elisa Giovannetti, Mona Maftouh, Carlotta Granchi, Niccola Funel, B. Aicher, A. Van Krieken, G.J. Peters, Amir Avan, Rajiv S. Raktoe, Lg Leon, Filippo Minutolo, Ugo Boggi

Publikováno v: European Journal of Cancer. 72:S86

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d7980d77afefc8cb1b796901ca85e26a
https://doi.org/10.1016/s0959-8049(17)30364-7

Abstract 76: Preoperative Genome-wide Differences in Inflammatory Gene Expression Predict Success Versus Failure in Lower Extremity Vein Bypass

Autor: Kerri A O’Malley, LG Leon Novelo, M Cecilia Lopez, Kenneth DeSart, Khayree Butler, Christian Restrepo, Lyle L Moldawer, Scott A Berceli, Henry V Baker, George Casella, Peter R Nelson

Publikováno v: Arteriosclerosis, Thrombosis, and Vascular Biology. 32

Introduction: Vein bypass grafting is standard surgical therapy in the treatment for peripheral arterial disease (PAD), especially for those with limb threatening ischemia. However, the durability of vein grafts remains problematic with recent studie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0b2bbefe7e9c38d312d424161e75cdbd
https://doi.org/10.1161/atvb.32.suppl_1.a76

Feasibility and user-experience of a virtual environment for social connection and education after stroke: A pilot study.

Autor: Beauchamp JES; Cizik School of Nursing, The University of Texas Health Science Center at Houston and the Institute for Stroke and Cerebrovascular Disease, 6901 Bertner Avenue, Houston, TX 77030, United States. Electronic address: Jennifer.E.Beauchamp@uth.tmc.edu., Wang M; School of Public Health, The University of Texas Health Science Center at Houston, 1200 Pressler Street, Houston, TX 77030, United States., Leon Novelo LG; School of Public Health, The University of Texas Health Science Center at Houston, 1200 Pressler Street, Houston, TX 77030, United States., Cox C; Cizik School of Nursing, The University of Texas Health Science Center at Houston and the Institute for Stroke and Cerebrovascular Disease, 6901 Bertner Avenue, Houston, TX 77030, United States., Meyer T; Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, 1941 East Road, Houston, TX 77030, United States., Fagundes C; Department of Psychological Sciences, Rice University, 6100 Main Street, Houston, TX 77005, United States., Savitz SI; Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston and the Institute for Stroke and Cerebrovascular Disease, 6431 Fannin, Houston, TX 77030, United States., Sharrief A; Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston and the Institute for Stroke and Cerebrovascular Disease, 6431 Fannin, Houston, TX 77030, United States., Dishman D; Cizik School of Nursing, The University of Texas Health Science Center at Houston and the Institute for Stroke and Cerebrovascular Disease, 6901 Bertner Avenue, Houston, TX 77030, United States., Johnson C; Cizik School of Nursing, The University of Texas Health Science Center at Houston and the Institute for Stroke and Cerebrovascular Disease, 6901 Bertner Avenue, Houston, TX 77030, United States.

Publikováno v: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2024 Feb; Vol. 33 (2), pp. 107515. Date of Electronic Publication: 2023 Dec 07.

Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey.

Autor: Swartz MD; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., DeSantis SM; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Yaseen A; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Brito FA; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Valerio-Shewmaker MA; The University of Texas Health Science Center in Houston, School of Public Health in Brownsville, Brownsville, Texas, USA., Messiah SE; The University of Texas Health Science Center in Houston, School of Public Health in Dallas, Dallas, Texas, USA., Leon-Novelo LG; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Kohl HW; The University of Texas Health Science Center in Houston, School of Public Health in Austin, Austin, Texas, USA.; The University of Texas at Austin, College of Education, Department of Kinesiology and Health Education, Austin, Texas, USA., Pinzon-Gomez CL; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Hao T; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Zhang S; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Talebi Y; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Yoo J; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Ross JR; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Gonzalez MO; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Wu L; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA., Kelder SH; The University of Texas Health Science Center in Houston, School of Public Health in Austin, Austin, Texas, USA., Silberman M; Clinical Pathology Laboratories, Austin, Texas, USA., Tuzo S; Clinical Pathology Laboratories, Austin, Texas, USA., Pont SJ; Texas Department of State Health Services, Austin, Texas, USA., Shuford JA; Texas Department of State Health Services, Austin, Texas, USA., Lakey D; University of Texas System, Office of Health Affairs, Austin, Texas, USA., Boerwinkle E; The University of Texas Health Science Center in Houston, School of Public Health in Houston, Houston, Texas, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2023 Jan 11; Vol. 227 (2), pp. 193-201.

miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia.

Autor: Assmann JLJC; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Leon LG; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Stavast CJ; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van den Bogaerdt SE; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Schilperoord-Vermeulen J; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Sandberg Y; Department of Hematology, Maasstadziekenhuis, Rotterdam, The Netherlands., Bellido M; Department of Hematology, Faculty of Medical Sciences, Groningen University Medical Center, Groningen, The Netherlands., Erkeland SJ; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Feith DJ; Division of Hematology/Oncology, Department of Medicine, UVA Cancer Center, University of Virginia, Charlottesville, VA, USA., Loughran TP Jr; Division of Hematology/Oncology, Department of Medicine, UVA Cancer Center, University of Virginia, Charlottesville, VA, USA., Langerak AW; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. a.langerak@erasmusmc.nl.; ACE Rare Immunological Diseases Center, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. a.langerak@erasmusmc.nl.

Publikováno v: Leukemia [Leukemia] 2022 Apr; Vol. 36 (4), pp. 983-993. Date of Electronic Publication: 2021 Dec 06.